Gamida Cell: Exploratory Endpoint Data from Omidubicel’s Phase 3 Study in Hematologic Malignancies – CBI
Homepage /  Press Release /  Gamida Cell: Exploratory Endpoint Data from Omidubicel’s Phase 3 Study in Hematologic Malignancies

Press Release

Gamida Cell: Exploratory Endpoint Data from Omidubicel’s Phase 3 Study in Hematologic Malignancies